ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1347

Ultrasonography and Synovial Histology in the RA Patients in Remission

Asami Abe1, Hajime Ishikawa2 and Kunihiko Wakaki3, 1Rheumatplogy, Niigata Rheumatic Center, Shibata, Japan, 2Department of Rheumatology, Niigata Rheumatic Center, Shibata, Japan, 3Pathology, Niigata Prefectural Shibata Hospital, Shibata, Japan

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: histopathologic, Rheumatoid arthritis (RA), synovitis and ultrasonography

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 6, 2017

Title: Rheumatoid Arthritis – Clinical Aspects Poster II: Pathophysiology, Autoantibodies, and Disease Activity Measures

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: In the treatment of rheumatoid arthritis (RA), the early diagnosis and early medical treatment via tight control have become increasingly important with the advent of biological therapy. Ultrasonography (US) for the affected joints enables the evaluation of synovial hypertrophy, effusion and bone erosion in real time. US is a reliable method that can detect more erosive sites than radiography. US is now utilized widely and is a reliable tool among rheumatologists for diagnosing RA and evaluating the disease activity. However, many patients have swollen, deformed and painful joints due to overuse and advancing bone destruction. This study was conducted to clarify the relationship between the systemic disease activity, local disease activity using US and a synovial histopathological evaluation in RA patients in remission (Disease Activity Score [DAS] 28-ESR[4]<2.6).

Methods: Between March 2011 and April 2017, 176 joints were surgically treated among all RA patients in remission, and synovial biopsies were performed at the time of surgery. Among them, a total of 52 fingers, 32 wrists, 57 toes, 3 ankles, 12 elbows, 3 shoulders and 17 knees were investigated. Just before surgery, the US probe was placed on the joints to evaluate the activity of local synovitis. The maximum grade of power Doppler (PD) signal was determined, ranging from 0 to 3. The serum C reactive protein (CRP), matrix metalloproteinase-3 (MMP-3) and DAS28 values were also examined just before surgery. A histopathological examination of the gathered synovium at the surgical site was performed using the Rooney score (RS). Biological disease-modifying antirheumatic drugs (BIO) were used in 73 cases, namely infliximab in 8 cases, etanercept in 10, adalimumab in 10, tocilizumab in 28, abatacept in 5, certolizumab pegol in 2 and golimumab in 10.

Results: The PD score was grade 0 in 76 cases, 1 in 61 cases, 2 in 30 cases and 3 in 9 cases. The average CRP was 0.17 mg/dL, and MMP-3 was 94.6 ng/mL, both low values. The three items of lymphocytes in the RS score showed low values, while synoviocyte hyperplasia and fibrosis showed high values due to a secondary reaction after inflammation at the joints. Group L consisted of 76 joints of grade 0, Group H included 61 joints of grade 1, 30 joints of grade 2 and 9 joints of grade 3. The values of MMP-3, synovium hyperplasia, lymphocyte infiltration and blood vessel hyperplasia were markedly low in Group L. Small Joints (SJ) consisted of 144 joints with fingers, wrists, feet and ankles. Large Joints (LJ) consisted of 32 joints with elbows, shoulders and knees. The values of MMP-3, synovium hyperplasia and high value were markedly low in SJ cases with blood vessel hyperplasia. Patients using BIO showed low values for CRP, synovium hyperplasia and lymphocyte infiltration.

Conclusion: The systemic disease activities, as indicated by DAS28, CRP and MMP-3, of RA patients in remission were low. However, synovitis was clearly present based on ultrasonography and histological findings of the surgical joints of PD-positive RA patients in remission.


Disclosure: A. Abe, None; H. Ishikawa, None; K. Wakaki, None.

To cite this abstract in AMA style:

Abe A, Ishikawa H, Wakaki K. Ultrasonography and Synovial Histology in the RA Patients in Remission [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/ultrasonography-and-synovial-histology-in-the-ra-patients-in-remission/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ultrasonography-and-synovial-histology-in-the-ra-patients-in-remission/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology